Clinical Chemistry, Malmö
181 – 190 of 1344
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years : A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
- Contribution to journal › Article
-
Mark
Advances in understanding mechanisms of thrombophilic disorders
- Contribution to journal › Scientific review
-
Mark
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
- Contribution to journal › Article
-
Mark
Genetic risk factors for venous thromboembolism
- Contribution to journal › Scientific review
- 2019
-
Mark
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men
(2019) In Prostate
- Contribution to journal › Article
-
Mark
Current status of clinical proteogenomics in lung cancer
- Contribution to journal › Scientific review
-
Mark
A Bacterial Effector Mimics a Host HSP90 Client to Undermine Immunity
- Contribution to journal › Article
-
Mark
A novel conserved family of Macro-like domains—putative new players in ADP-ribosylation signaling
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
- Contribution to journal › Article
-
Mark
PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization
(2019) In Proceedings of the National Academy of Sciences of the United States of America 116(31). p.15495-15504
- Contribution to journal › Article
